• Company
• Will the flu vaccine market rebound?
• by May 2, 2022 06:03am

• Company
• Rozlytrek can be prescribed with reimb in Korea
• by Eo, Yun-Ho May 2, 2022 06:02am

• Policy
• New cost of Tecentriq is 2,271,109 won
• by Kim, Jung-Ju May 2, 2022 06:02am

• Company
• Daewoong - AZ Targets Asian Market with Crezet
• by Chon, Seung-Hyun May 2, 2022 06:02am

• Company
• The size of the DPP-4 diabetes Rx market is decreasing
• by Apr 29, 2022 05:42am

• Company
• Zolgensma makes one step towards reimbursement
• by Eo, Yun-Ho Apr 29, 2022 05:42am

• Company
• Sale of Atozet generics exceeds its orignial in 1 year
• by Kim, Jin-Gu Apr 29, 2022 05:42am

• Company
• LG Chem will jointly sell Nesp & Regpara with Kyowa Kirin
• by Kim, Jin-Gu Apr 29, 2022 05:41am

• Policy
• Combi of HBP+ Hyperlipidemia will be released again
• by Lee, Tak-Sun Apr 29, 2022 05:41am

• Company
• Immunotherapy Opdivo reattempts reimb in gastric cancer
• by Eo, Yun-Ho Apr 28, 2022 06:07am